Introduction {#tmi12651-sec-0005}
============

Despite the rising tide of non‐communicable disease (NCD) in sub‐Saharan Africa (SSA), few studies have assessed the burden of kidney disease in this region [1](#tmi12651-bib-0001){ref-type="ref"}. Health facility data indicate that kidney disease is common, including our own study from western Tanzania, which demonstrated that kidney disease was the 6th leading cause of hospital deaths [2](#tmi12651-bib-0002){ref-type="ref"}. Studies of the general population, though, are lacking. According to a recent meta‐analysis, only three high‐quality epidemiological surveys had been conducted in SSA, and none had compared the prevalence of kidney disease in urban and rural settings [1](#tmi12651-bib-0001){ref-type="ref"}.

Risk factors for kidney disease in SSA are also poorly described and may differ from those in the United States and Europe [3](#tmi12651-bib-0003){ref-type="ref"}, [4](#tmi12651-bib-0004){ref-type="ref"}, and between urban and rural areas [3](#tmi12651-bib-0003){ref-type="ref"}, [5](#tmi12651-bib-0005){ref-type="ref"}. Infectious risk factors for kidney disease remain common in SSA, particularly in rural areas [5](#tmi12651-bib-0005){ref-type="ref"}. Non‐infectious risk factors such as diabetes, hypertension and obesity are now becoming increasingly prevalent, particularly in urban areas [6](#tmi12651-bib-0006){ref-type="ref"}. Better understanding of risk factors for kidney disease in sub‐Saharan Africa is critical for planning clinical trials and improving services [3](#tmi12651-bib-0003){ref-type="ref"}, [4](#tmi12651-bib-0004){ref-type="ref"}, [5](#tmi12651-bib-0005){ref-type="ref"}.

We determined estimated glomerular filtration rates (eGFRs) in a large community survey of randomly selected, representative samples of adults in rural communities, district towns and urban areas in north‐western Tanzania. The objectives of our study were as follows: (i) to determine the distribution of decreased eGFR in the three study locations, (ii) to systematically describe factors associated with low eGFR and (iii) to quantify the proportion of low eGFRs that were attributable to HIV, hypertension and diabetes.

Methods {#tmi12651-sec-0006}
=======

Study design and sampling {#tmi12651-sec-0007}
-------------------------

This study was part of a larger population survey of chronic diseases that we conducted between May 2012 and April 2013 among adults (≥18 years) in north‐western Tanzania (in the Lake Zone located just south of Lake Victoria). We used stratified, multistage sampling, with five strata: a municipal area (Mwanza city), two district towns (Geita and Kahama) and the rural communities corresponding to each district town. The adults population of these municipal areas, district towns and rural communities are similar to other parts of East Africa with adult median age of \~33 years, \~55% females, a median income of \~40 USD, \~25% secondary education or higher and \~6% prevalence of HIV [7](#tmi12651-bib-0007){ref-type="ref"}. The major tribe in the study area is the Sukuma tribe, a Bantu ethnic group. We took an independent two‐stage self‐weighting sample from each stratum, firstly sampling areas with probability proportional to the number of households, and secondly randomly sampling households within these areas. Households (the primary sampling unit) were eligible if they were located within 5 km of a health facility. Selected households were visited, verbal consent from household heads was obtained, a list of adult household members prepared, and all resident adults were invited to participate. Consenting participants were recruited. The sampling strategy is described in greater detail elsewhere [7](#tmi12651-bib-0007){ref-type="ref"}.

Data collection {#tmi12651-sec-0008}
---------------

Consenting participants were interviewed in their homes or communal places using a structured questionnaire adapted from the WHO STEPwise approach to chronic disease risk factor surveillance (STEPS) instrument [8](#tmi12651-bib-0008){ref-type="ref"}. We collected information on sociodemographic characteristics and risk factors for non‐communicable diseases (NCDs) including alcohol use, smoking, diet and physical activity. Weight and height were measured according to the STEPS protocol. Three blood pressure (BP) measurements were taken in seated participants after resting for at least 15 min, using Omron^®^ digital automatic BP monitor model M6 (Omron Health Care Manufacturing Vietnam Co., Ltd, Binh Duong Province, Vietnam). The third reading was used for analysis.

Laboratory methods {#tmi12651-sec-0009}
------------------

At the time of enrolment, venous blood samples were obtained. Serum aliquots were stored in a portable freezer (−20 °C) and transported (within 5 days) to the National Institute for Medical Research Laboratory in Mwanza city, where they were stored at −80 °C. Serum samples were later transported to the MRC/UVRI Uganda Research Unit on AIDS in Entebbe, where serum creatinine was measured using Cobas Integra 400 Plus Analyzer (Roche Diagnostic Limited, Switzerland), calibrated by the creatinine Jaffe 2 method. Capillary random blood glucose (RBG) was measured using a portable, battery‐driven Accu‐Check^®^ Aviva (Roche Diagnostics GmbH, Mannheim, Germany), and rapid HIV diagnostic tests were performed according to national protocols. In study subjects with an elevated RBG (≥7 mmol/l), a fasting blood sample was subsequently obtained for measurement of fasting blood glucose (FBG). Other laboratory methods were previously described in detail [7](#tmi12651-bib-0007){ref-type="ref"}.

Definitions {#tmi12651-sec-0010}
-----------

The primary outcome of this study was decreased renal function according to the estimated glomerular filtration rate (eGFR). For this study, decreased renal function was defined as eGFR\<60 ml/min/1.73 m^2^ according to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines [9](#tmi12651-bib-0009){ref-type="ref"}. The eGFR was calculated using the CKD‐EPI equation as this is recommended by KDIGO and is the most accurate eGFR equation for African adults [9](#tmi12651-bib-0009){ref-type="ref"}, [10](#tmi12651-bib-0010){ref-type="ref"}, [11](#tmi12651-bib-0011){ref-type="ref"}, [12](#tmi12651-bib-0012){ref-type="ref"}. The grade of renal function was also defined according to KDIGO guidelines: normal (eGFR≥90); mildly decreased (eGFR 60--89); mildly--moderately decreased (eGFR 45--59); moderately--severely decreased (eGFR 30--44); severely decreased (eGFR 15--29); and kidney failure (eGFR \< 15) [9](#tmi12651-bib-0009){ref-type="ref"}. For the sake of comparison, we also calculated the eGFR using the Modified Diet Renal Disease (MDRD) equation. All eGFR calculations were performed without the coefficient for ethnicity because this coefficient has been shown to overestimate the actual glomerular filtration rate among Africans [10](#tmi12651-bib-0010){ref-type="ref"}, [11](#tmi12651-bib-0011){ref-type="ref"}, [12](#tmi12651-bib-0012){ref-type="ref"}.

Hypertension was defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg or current antihypertensive therapy [13](#tmi12651-bib-0013){ref-type="ref"}. Diabetes mellitus was defined as FBG ≥7 mmol/L or RBG \>11.1 mmol/l or being on diabetes medication. Body mass index (BMI, kg/m2) was classified as underweight (\<18.5), normal (18.5 to \<25), overweight (25 to \<30) and obese (≥30). Waist circumference \>94 cm and \>80 cm was classified as above normal (central obesity) for males and females.

Statistical analysis {#tmi12651-sec-0011}
--------------------

Data were double entered and verified in OpenClinica^®^ version 3.0.1 (OpenClinica, Waltham, USA). We used the survey commands of Stata version 13 (Stata Corporation, College Station, USA) to account for the complex sampling design, with standard errors adjusted for clustering at the level of the primary sampling unit. We applied strata sampling weights to account for differential probability of selection between strata, as has been described in greater detail elsewhere [7](#tmi12651-bib-0007){ref-type="ref"}.

We estimated the population prevalence of decreased renal function based on the CKD‐EPI and MDRD equations, stratified by location (Mwanza city, district towns and rural), using weighted percentages and confidence intervals (CI) but observed (i.e. unweighted) frequencies. In addition, prevalences were age standardised using both the United States 2000 population and the WHO world population as references as we have previously reported for hypertension and diabetes mellitus [7](#tmi12651-bib-0007){ref-type="ref"}.

We assessed the agreement of the classification based on the MDRD with that based on the CKD‐EPI equation using a Kappa statistic, with the Landis and Koch interpretation for the strength of agreement [14](#tmi12651-bib-0014){ref-type="ref"}.

We used logistic and linear regression to investigate factors associated with the prevalence of decreased renal function (eGFR \< 60 ml/min/1.73 m^2^, based on CKD‐EPI equation) and of mean eGFR, respectively, and estimated regression coefficients (odds ratios (OR) and mean change) and 95% CI using the Stata survey procedures to adjust the standard errors for the survey design. Sampling weights were not applied in the risk factor analyses. We adjusted for age, sex and location *a priori* in all models, so comparisons were essentially within location. We estimated the population attributable fraction (PAF) of decreased renal function for HIV, hypertension and diabetes using the adjusted ORs from the final model. The joint PAF for HIV, hypertension and diabetes was calculated by generating a new variable to represent the eight possible combinations of the 3 CDs: none of the 3, HIV only, hypertension only, diabetes only, HIV and hypertension, HIV and diabetes, hypertension and diabetes, and all 3 CDs. This new variable was then included in a logistic regression model adjusted for age, sex and location. The adjusted (a)ORs from this model multiplied by the proportion of cases of low eGFR in each of the categories by the attributable fraction in the exposed (1‐aOR)/aOR); these values were then summed to get the overall PAF.

Potential determinants of mean eGFRs were examined using a conceptual framework with three levels. Age, sex and location were included in all models. Sociodemographic factors (e.g. education, marital status, income group) were added one by one to the age‐, sex‐ and location‐adjusted analysis and retained if associated with mean eGFR at *P* \< 0.10. Behavioural factors (e.g. smoking, diet, alcohol intake) were then added one by one and retained if they remained associated at *P* \< 0.10. Associations with clinical factors (e.g. body mass index, hypertension, diabetes) were subsequently determined in a similar way. This strategy allowed us to assess the effects of variables at each level of the framework, adjusted for more distal variables.

Ethical considerations {#tmi12651-sec-0012}
----------------------

This study was approved by the ethics committees of the Tanzania National Institute for Medical Research and the London School of Hygiene and Tropical Medicine. We obtained written informed consent from all participants (or by literate witnesses for illiterate participants) before administering study procedures. Participants were interviewed in private to ensure confidentiality. Participants with any untreated or newly diagnosed conditions referred to a local health facility for further assessment, counselling, and long‐term care and treatment. All procedures were consistent with ethical standards of the Helsinki Declaration.

Results {#tmi12651-sec-0013}
=======

Enrolment {#tmi12651-sec-0014}
---------

Between August 2012 and April 2013, we sampled 625 households of which 563 (90%) agreed to participate. There were 1374 eligible adults in the participating households, and 1095 (80% of those eligible) consented to the survey, resulting in an estimated 72% response rate. Among adults surveyed, creatinine measurements were available for 1043: 170 of 175 (97%) adults in Mwanza city, 326 of 344 (95%) in district towns and 547 of 576 (95%) in rural areas.

Characteristics of the study population {#tmi12651-sec-0015}
---------------------------------------

Among 1043 study participants with data on eGFR, the mean age was 35.5 years (SD = 15.3 years) and 566 (54.3%) were female; 852 (81.7%) had only a primary education or less and 731 (74.4%) earned \<64 USD per month (Table [1](#tmi12651-tbl-0001){ref-type="table-wrap"}). Regarding clinical characteristics, 197 (18.5%) were overweight or obese, 180 (17.3%) had hypertension, 9 (0.9%) had diabetes mellitus and 87 (8.4%) were HIV seropositive.

###### 

Population characteristics and factors associated with decreased renal function (eGFR \<60 ml/min/1.73 m^2^) among adults in a population survey in north‐western Tanzania, 2012--2013

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                    Total N (column %)[a](#tmi12651-note-0001){ref-type="fn"}   Prevalence of eGFR \< 60 (row %)[a](#tmi12651-note-0001){ref-type="fn"}   Unadjusted OR (95% CI)[b](#tmi12651-note-0002){ref-type="fn"}   Age‐, sex‐, and residence‐adjusted OR (95% CI)[b](#tmi12651-note-0002){ref-type="fn"}
  --------------------------------------------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------------------------------
  Sociodemographic                                                                                                                                                                                                                                                                        

  Residence                                                                                                                                                                                                               *P* = 0.11                                                      *P* = 0.12

  Mwanza city                                                                       170 (16.3%)                                                 4 (2.4%)                                                                  1                                                               1

  District towns                                                                    326 (31.3%)                                                 23 (7.1%)                                                                 3.15 (0.97--10.27)                                              3.37 (1.07--10.64)

  Rural                                                                             547 (52.4%)                                                 42 (7.7%)                                                                 3.45 (1.09--10.89)                                              2.96 (0.94--9.33)

  Age group                                                                                                                                                                                                               *P* \< 0.001                                                    *P* \< 0.001

  \<25 years                                                                        293 (28.1%)                                                 10 (3.4%)                                                                 1                                                               1

  25--34 years                                                                      326 (31.3%)                                                 16 (4.9%)                                                                 1.46 (0.68--3.15)                                               1.45 (0.68--3.08)

  35--44 years                                                                      167 (16.0%)                                                 12 (7.2%)                                                                 2.19 (1.27--3.77)                                               2.16 (1.27--3.66)

  ≥45 years                                                                         257 (24.6%)                                                 31 (12.1%)                                                                3.88 (2.18--6.90)                                               3.82 (2.16--6.74)

  Sex                                                                                                                                                                                                                     *P* = 0.34                                                      *P* = 0.52

  Male                                                                              477 (45.7%)                                                 35 (7.3%)                                                                 1                                                               1

  Female                                                                            566 (54.3%)                                                 34 (6.0%)                                                                 0.81 (0.52--1.26)                                               0.87 (0.57--1.34)

  Education                                                                                                                                                                                                               *P* = 0.12                                                      *P* = 0.76

  Secondary or above                                                                191 (18.3%)                                                 9 (4.7%)                                                                  1                                                               1

  Completed primary                                                                 491 (47.1%)                                                 29 (5.9%)                                                                 1.27 (0.55--2.94)                                               0.91 (0.38--2.20)

  None/incomplete primary                                                           361 (34.6%)                                                 31 (8.6%)                                                                 1.90 (0.90--4.03)                                               1.12 (0.47--2.66)

  Marital status                                                                                                                                                                                                          *P* = 0.06                                                      *P* = 0.49

  Married/living as married                                                         674 (64.6%)                                                 45 (6.7%)                                                                 1                                                               1

  Divorced/sep/widowed                                                              163 (15.6%)                                                 17 (10.4%)                                                                1.63 (0.90--2.94)                                               1.46 (0.78--2.71)

  Single                                                                            206 (19.8%)                                                 7 (3.4%)                                                                  0.49 (0.22--1.12)                                               0.85 (0.24--3.03)

  Income per month[c](#tmi12651-note-0003){ref-type="fn"}                                                                                                                                                                 *P* = 0.30                                                      *P* = 0.18

  Upper tertile (64 + USD)                                                          251 (25.6%)                                                 13 (5.2%)                                                                 1                                                               1

  Middle tertile (26--63 USD)                                                       262 (26.7%)                                                 22 (8.4%)                                                                 1.68 (0.86--3.28)                                               1.87 (0.95--3.69)

  Lower tertile (\<26 USD)                                                          469 (47.8%)                                                 30 (6.4%)                                                                 1.25 (0.66--2.36)                                               1.29 (0.65--2.58)

  Items owned                                                                                                                                                                                                             *P* = 0.02                                                      *P* = 0.02

  5+                                                                                262 (25.1%)                                                 24 (9.2%)                                                                 1                                                               1

  2--4                                                                              668 (64.0%)                                                 35 (5.2%)                                                                 0.55 (0.36--0.84)                                               0.54 (0.35--0.83)

  0--1                                                                              113 (10.8%)                                                 10 (8.8%)                                                                 0.96 (0.43--2.15)                                               0.80 (0.33--1.91)

  Behavioural                                                                                                                                                                                                                                                                             

  Smoking                                                                                                                                                                                                                 *P* = 0.18                                                      *P* = 0.89

  Never smoked                                                                      856 (82.1%)                                                 52 (6.1%)                                                                 1                                                               1

  Ex--smoker                                                                        79 (7.6%)                                                   8 (10.1%)                                                                 1.74 (0.91--3.35)                                               1.17 (0.60--2.29)

  Current smoker                                                                    108 (10.4%)                                                 9 (8.3%)                                                                  1.41 (0.62--3.19)                                               0.94 (0.38--2.31)

  Alcohol consumption                                                                                                                                                                                                     *P* = 0.34                                                      *P* = 0.57

  Never drinks                                                                      669 (64.1%)                                                 40 (6.0%)                                                                 1                                                               1

  None in past 12 months                                                            237 (22.7%)                                                 21 (8.9%)                                                                 1.53 (0.84--2.80)                                               1.15 (0.60--2.23)

  Drinking in past 12 months                                                        137 (13.1%)                                                 8 (5.8%)                                                                  0.98 (0.38--2.52)                                               0.71 (0.28--1.80)

  Eats fruit/veg less than 5 days/week                                                                                                                                                                                    *P* = 0.05                                                      *P* = 0.11

  No                                                                                771 (73.9%)                                                 58 (7.5%)                                                                 1                                                               1

  Yes                                                                               272 (26.1%)                                                 11 (4.0%)                                                                 0.52 (0.27--1.00)                                               0.58 (0.30--1.14)

  Days of vigorous physical activity/week[d](#tmi12651-note-0004){ref-type="fn"}                                                                                                                                          *P* = 0.26                                                      *P* = 0.07

  5+                                                                                500 (48.0%)                                                 28 (5.6%)                                                                 1                                                               1

  1--4                                                                              135 (13.0%)                                                 8 (5.9%)                                                                  1.06 (0.50--2.27)                                               1.31 (0.60--2.85)

  None                                                                              407 (39.1%)                                                 33 (8.1%)                                                                 1.49 (0.88--2.52)                                               1.81 (1.09--3.00)

  Clinical                                                                                                                                                                                                                                                                                

  Body Mass Index (BMI) category (kg/m^2^)[e](#tmi12651-note-0005){ref-type="fn"}                                                                                                                                         *P* = 0.61                                                      *P* = 0.83

  Underweight (\<18.5)                                                              109 (10.5%)                                                 11 (10.1%)                                                                1.73 (0.69--4.29)                                               1.52 (0.62--3.77)

  Normal (18.5--\<25)                                                               737 (71.0%)                                                 45 (6.1%)                                                                 1                                                               1

  Overweight (25--\<30)                                                             123 (11.8%)                                                 8 (6.5%)                                                                  1.07 (0.57--2.02)                                               0.97 (0.49--1.91)

  Obese (≥30)                                                                       69 (6.6%)                                                   5 (7.2%)                                                                  1.20 (0.51--2.81)                                               0.92 (0.37--2.28)

  Central Obesity[f](#tmi12651-note-0006){ref-type="fn"}                                                                                                                                                                  *P* = 0.97                                                      *P* = 0.70

  No                                                                                784 (75.2%)                                                 52 (6.6%)                                                                 1                                                               1

  Yes                                                                               259 (24.8%)                                                 17 (6.6%)                                                                 0.99 (0.52--1.90)                                               0.85 (0.38--1.94)

  Hypertension                                                                                                                                                                                                            *P* = 0.003                                                     *P* = 0.11

  No                                                                                863 (82.7%)                                                 46 (5.3%)                                                                 1                                                               1

  Yes                                                                               180 (17.3%)                                                 23 (12.8%)                                                                2.60 (1.41--4.78)                                               1.84 (0.87--3.89)

  Systolic blood pressure (mmHg)                                                                                                                                                                                                                                                          

  \<120                                                                             448 (43.0%)                                                 23 (5.1%)                                                                 *P* = 0.005\                                                    *P* = 0.14\
                                                                                                                                                                                                                          1.20 (1.06--1.36)[i](#tmi12651-note-0150){ref-type="fn"}        1.12 (0.96--1.30)[i](#tmi12651-note-0150){ref-type="fn"}

  120--140                                                                          445 (42.7%)                                                 28 (6.3%)                                                                                                                                 

  \>140                                                                             150 (14.4%)                                                 18 (12.0%)                                                                                                                                

  Diastolic blood pressure (mmHg)                                                                                                                                                                                                                                                         

  \<80                                                                              748 (71.7%)                                                 40 (5.3%)                                                                 *P* = 0.008\                                                    *P* = 0.13\
                                                                                                                                                                                                                          1.35 (1.09--1.68)[h](#tmi12651-note-0008){ref-type="fn"}        1.22 (0.94--1.57)[h](#tmi12651-note-0008){ref-type="fn"}

  80--90                                                                            210 (20.1%)                                                 16 (7.6%)                                                                                                                                 

  \>90                                                                              85 (8.1%)                                                   13 (15.3%)                                                                                                                                

  Diabetes[g](#tmi12651-note-0007){ref-type="fn"}                                                                                                                                                                         *P* = 0.54                                                      *P* = 0.84

  No                                                                                1031 (99.1%)                                                67 (6.5%)                                                                 1                                                               1

  Yes                                                                               9 (0.9%)                                                    1 (11.1%)                                                                 1.80 (0.26--12.24)                                              1.21 (0.19--7.84)

  HIV positive[h](#tmi12651-note-0008){ref-type="fn"}                                                                                                                                                                     *P* = 0.06                                                      *P* = 0.08

  No                                                                                947 (91.6%)                                                 59 (6.2%)                                                                 1                                                               1

  Yes                                                                               87 (8.4%)                                                   9 (10.3%)                                                                 1.74 (0.99--3.06)                                               1.68 (0.93--3.04)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Actual number of respondents and proportions, without sampling weights applied.

Standard errors and 95% CI adjusted for clustering in survey design.

Missing for 61 participants.

Missing for one participant. Vigorous physical activity was defined as 'activity that causes large increases in breathing or heart rate like carrying or lifting heavy loads, very brisk walking, digging or construction work for at least 10 min continuously'.

Missing for five participants.

Central obesity was defined as a waist circumference of \>0.94 for women and waist circumference \>0.80 for men.

Missing for three participants.

HIV diagnosis missing for nine participants.

OR for 10 unit mmHg increase in blood pressure, modelled as a linear association with continuous covariate.
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Renal function outcomes {#tmi12651-sec-0016}
-----------------------

According to the CKD‐EPI equation, the mean (95% CI) eGFRs (ml/min/1.73 m^2^) were 114.5 (109.9--119.0), 110.2 (106.9--113.5) and 107.7 (105.4--110.1) in Mwanza city, district towns and rural areas, respectively (Table [2](#tmi12651-tbl-0002){ref-type="table-wrap"}). Similar estimates were obtained with the MDRD equation. The prevalence (95% CI) of decreased renal function (defined by eGFR\<60 ml/min/1.73 m^2^) was 2.3% (0.8--6.6%), 7.5% (4.7--11.8%) and 7.4% (5.1--10.6%) in Mwanza city, district towns and rural areas, respectively. There were no cases of moderately--severe or severely decreased eGFR in Mwanza city, compared with 2.7% in district towns and 2.2% in rural areas. When standardised to the US 2000 population, the prevalence of decreased renal function was 5.1%, 11.0% and 9.4% in Mwanza city, district towns and rural areas, respectively (Figure [1](#tmi12651-fig-0001){ref-type="fig"}).

###### 

Mean serum creatinine and eGFR, and prevalence of decreased renal function among adults in a population survey in north‐western Tanzania, 2012--2013

                                                                                                    Mwanza city (*n* = 170)   District towns (*n* = 326)   Rural (*n* = 547)
  ------------------------------------------------------------------------------------------------- ------------------------- ---------------------------- ----------------------
  Serum creatinine (mg/dl)                                                                          0.73 (0.69--0.77)         0.80 (0.76--0.84)            0.79 (0.76--0.81)
  Estimated GFR (ml/min/1.73 m^2^)                                                                                                                         
  CKD‐EPI equation[b](#tmi12651-note-0010){ref-type="fn"},[c](#tmi12651-note-0011){ref-type="fn"}   114.5 (109.9--119.0)      110.2 (106.9--113.5)         107.7 (105.4--110.1)
  MDRD equation[b](#tmi12651-note-0010){ref-type="fn"},[c](#tmi12651-note-0011){ref-type="fn"}      116.8 (105.9--127.7)      110.0 (105.8--114.2)         111.1 (107.1--115.0)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                        Weighted %\                                       Unweighted N[d](#tmi12651-note-0013){ref-type="fn"}   Weighted %\                                       Unweighted N[d](#tmi12651-note-0013){ref-type="fn"}   Weighted % (95% CI)[a](#tmi12651-note-0009){ref-type="fn"}   Unweighted N[d](#tmi12651-note-0013){ref-type="fn"}
                                                                                                                        (95% CI)[a](#tmi12651-note-0009){ref-type="fn"}                                                         (95% CI)[a](#tmi12651-note-0009){ref-type="fn"}                                                                                                                      
  --------------------------------------------------------------------------------------------------------------------- ------------------------------------------------- ----------------------------------------------------- ------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------ -----------------------------------------------------
  KDIGO Kidney disease category[e](#tmi12651-note-0014){ref-type="fn"}                                                                                                                                                                                                                                                                                                                               

  Normal (eGFR ≥90)                                                                                                     87.4 (79.6--92.5)                                 150                                                   81.6 (76.6--85.7)                                 266                                                   79.4 (75.5--82.9)                                            432

  Mildly decreased (eGFR 60--89)                                                                                        10.3 (5.9--17.4)                                  16                                                    10.9 (8.8--13.5)                                  37                                                    13.9 (10.3--16.7)                                            73

  Mildly--moderately decreased (eGFR 45--59)                                                                            2.3 (0.8--6.6)                                    4                                                     4.8 (2.7--8.4)                                    15                                                    5.3 (3.3--8.2)                                               30

  Moderately--severely decreased (eGFR 30--44)                                                                          0                                                 0                                                     2.4 (0.8--6.9)                                    7                                                     1.6 (0.9--2.8)                                               10

  Severely decreased (eGFR 15--29)                                                                                      0                                                 0                                                     0.3 (0.0--2.3)                                    1                                                     0.6 (0.1--1.9)                                               2

  Kidney failure (eGFR \<15)                                                                                            0                                                 0                                                     0                                                 0                                                     0                                                            0

  eGFR \<60 ml/min/1.73 m^2^ (CKD‐EPI)[b](#tmi12651-note-0010){ref-type="fn"},[c](#tmi12651-note-0011){ref-type="fn"}                                                                                                                                                                                                                                                                                

  Yes                                                                                                                   2.3 (0.8--6.6)                                    4                                                     7.5 (4.7--11.8)                                   23                                                    7.4 (5.1--10.6)                                              42

  Age \<20 years                                                                                                        0                                                 0                                                     5.6 (1.8--16.3)                                   2                                                     0                                                            0

  Age 20--39 years                                                                                                      0                                                 0                                                     7.6 (4.4--12.6)                                   15                                                    5.9 (3.1--10.7)                                              17

  Age 40--59 years                                                                                                      8.5 (2.8--22.8)                                   3                                                     5.5 (1.3--20.6)                                   3                                                     9.6 (5.1--17.3)                                              14

  Age ≥60 years                                                                                                         7.8 (0.8--46.2)                                   1                                                     18.6 (5.6--47.1)                                  3                                                     14.8 (6.9--28.7)                                             11

  eGFR \<60 ml/min/1.73 m^2^ (MDRD)[b](#tmi12651-note-0010){ref-type="fn"},[c](#tmi12651-note-0011){ref-type="fn"}                                                                                                                                                                                                                                                                                   

  Yes                                                                                                                   3.7 (1.5--8.5)                                    6                                                     9.4 (6.0--14.5)                                   29                                                    10.2 (7.8--13.2)                                             59
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are weighted estimates, adjusted for survey design with sampling weights applied.

The CKD‐EPI eGFR calculations were used as the primary outcomes in this study. The MDRD eGFR calculation is provided for the sake of comparison.

Without coefficient for black race.

Actual number of respondents, without sampling weights applied.

Based on CKD‐EPI equation without coefficient for race.

John Wiley & Sons, Ltd

![Prevalence of decreased renal function among adults ≥18 years in a population survey in north‐western Tanzania, age‐standardised to the US population and the WHO world population.](TMI-21-393-g001){#tmi12651-fig-0001}

The agreement between the CKD‐EPI equation with the MDRD equations in the classification of decreased renal function (eGFR \< 60 ml/min/1.73 m^2^) was excellent (kappa = 0.83) (Table [3](#tmi12651-tbl-0003){ref-type="table-wrap"}). Study subjects with eGFR\<60 ml/min/1.73 m^2^ by the CKD‐EPI equation (69/69 (100%)) also had eGFR\<60 ml/min/1.73 m^2^ by the MDRD equation.

###### 

Agreement between different measurements of chronic kidney disease (eGFR \<60 ml/min/1.73 m^2^) using CKD‐EPI equation *vs* MDRD equation among adults in a population survey in north‐western Tanzania, 2012--2013

  eGFR \<60 ml/min/1.73 m^2^ (CKD‐EPI)   eGFR \<60 ml/min/1.73 m^2^ (MDRD)                            
  -------------------------------------- ----------------------------------- ----------- ------------ ------------
  No                                     949 (97.4%)                         25 (2.6%)   969 (100%)   0.83
  Yes                                    0                                   69 (100%)   69 (100%)    P \< 0.001

Actual number of respondents and proportions, without sampling weights applied.

John Wiley & Sons, Ltd

Factors associated with decreased renal function {#tmi12651-sec-0017}
------------------------------------------------

People living in district towns had a higher odds of eGFR \< 60 ml/min/1.73 m^2^ (adjusted (a)OR = 3.37, 95% CI = 1.07--10.64) (Table [1](#tmi12651-tbl-0001){ref-type="table-wrap"}). Increasing age was strongly associated with decreased renal function. Adults aged 35--44 years and ≥45 years had 2.16 (95% CI = 1.27--3.66) and 3.82 (95% CI = 2.16--6.74) greater adjusted odds of decreased renal function compared with adults \<25 years old, after adjusting for sex and residence. Similarly, people who were not engaged in vigorous physical activity had greater odds of decreased renal function (aOR = 1.81, 95% CI = 1.09--3.00), when compared with those engaged in vigorous activity ≥5 days a week. Decreased renal function was also associated with ownership of household items, with prevalence highest among those owning more items (*P* = 0.02). However, the prevalence of decreased renal function was also relatively higher among those in the lower income group *vs* the middle income group.

Hypertension was associated with decreased renal function in the unadjusted analysis (OR = 2.60, 95% CI = 1.41--4.78; *P* = 0.008) but this association was weakened in the adjusted analysis (aOR = 1.84, 95% CI = 0.87--3.89; *P* = 0.14). Similar trends were observed for both systolic and diastolic blood pressures. We also observed some evidence of an increased odds of decreased renal function among those who were HIV positive (aOR = 1.68, 95% CI = 0.93--3.04; *P* = 0.08).

Factors associated with mean eGFR {#tmi12651-sec-0018}
---------------------------------

After adjustment, people living in district towns had a lower mean eGFR (−5.89 ml/min/1.73 m^2^, 95% CI = \[−10.94, −0.84\]) (Table [4](#tmi12651-tbl-0004){ref-type="table-wrap"}). Age was strongly associated with decreasing mean eGFR. After adjusting for sex and location, adults aged ≥45 years had a mean eGFR that was 35 ml/min/1.73 m^2^ lower than that of adults under 25 years of age (95% CI = \[−38, −31\]). In the adjusted analysis, there was also some evidence of a decrease in mean eGFR with increased ownership of household items (*P* = 0.05); however, there was no evidence of an association with other sociodemographic factors.

###### 

Mean serum creatinine and eGFR, and prevalence of decreased renal function among adults in a population survey in north‐western Tanzania, 2012--2013

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                        Total N[a](#tmi12651-note-0016){ref-type="fn"}   Mean eGFR[a](#tmi12651-note-0016){ref-type="fn"}   Unadjusted regression coefficient (95% CI)[b](#tmi12651-note-0017){ref-type="fn"}   Age, sex and residence‐adjusted regression coefficient (95% CI)[b](#tmi12651-note-0017){ref-type="fn"}   
  ----------------------------------------------------- ------------------------------------------------ -------------------------------------------------- ----------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------
  Sociodemographic                                                                                                                                                                                                                                                                                                                                       

  Residence                                                                                                                                                 *P* = 0.03                                                                          *P* = 0.08                                                                                               

  Mwanza city                                           170                                              114.9                                              0 (ref)                                                                             0 (ref)                                                                                                  

  District towns                                        326                                              110.4                                              −4.58 \[−10.67, 1.50\]                                                              −5.89 \[−10.94, −0.84\]                                                                                  

  Rural                                                 547                                              107.2                                              −7.75 \[−13.64, −1.87\]                                                             −4.15 \[−8.92, 0.62\]                                                                                    

  Age group                                                                                                                                                 *P* \< 0.001                                                                        *P* \< 0.001                                                                                             

  \<25 years                                            293                                              124.9                                              0 (ref)                                                                             0 (ref)                                                                                                  

  25--34 years                                          326                                              113.8                                              −11.16 \[−14.79, −7.53\]                                                            −11.13 \[−14.69, −7.58\]                                                                                 

  35--44 years                                          167                                              103.4                                              −21.53 \[−26.10, −16.96\]                                                           −21.76 \[−26.31, −17.21\]                                                                                

  ≥45 years                                             257                                              90.2                                               −34.70 \[−38.11, −31.29\]                                                           −34.87 \[−38.32, −31.42\]                                                                                

  Sex                                                                                                                                                       *P* = 0.97                                                                          *P* = 0.18                                                                                               

  Male                                                  477                                              109.4                                              0 (ref)                                                                             0 (ref)                                                                                                  

  Female                                                566                                              109.5                                              0.05 \[−2.69, 2.79\]                                                                −1.56 \[−3.87, 0.75\]                                                                                    

  Education                                                                                                                                                 *P* \< 0.001                                                                        *P* = 0.48                                                                                               

  Secondary or above                                    191                                              116.1                                              0 (ref)                                                                             0 (ref)                                                                                                  

  Complete primary                                      491                                              109.8                                              −6.25 \[−10.44, −2.06\]                                                             1.33 \[−2.65, 5.31\]                                                                                     

  None/incomplete primary                               361                                              105.5                                              −10.60 \[−14.58, −6.62\]                                                            2.83 \[−1.83, 7.49\]                                                                                     

  Marital status                                                                                                                                            *P* \< 0.001                                                                        *P* = 0.31                                                                                               

  Married/living as married                             674                                              107.4                                              0 (ref)                                                                             0 (ref)                                                                                                  

  Divorced/sep/widowed                                  163                                              99.7                                               −7.62 \[−12.70, −2.55\]                                                             −1.53 \[−5.80, 2.73\]                                                                                    

  Single                                                206                                              124.0                                              16.65 \[12.29, 21.02\]                                                              3.11 \[−1.99, 8.21\]                                                                                     

  Income per month                                                                                                                                          *P* = 0.64                                                                          *P* = 0.18                                                                                               

  Upper tertile (64 + USD)                              251                                              108.0                                              0 (ref)                                                                             0 (ref)                                                                                                  

  Middle tertile (26--63 USD)                           262                                              109.1                                              1.12 \[−3.71, 5.96\]                                                                0.50 \[−3.89, 4.89\]                                                                                     

  Lower tertile (\<26 USD)                              469                                              109.9                                              1.90 \[−2.13, 5.92\]                                                                2.69 \[−0.85, 6.24\]                                                                                     

  Items owned                                                                                                                                               *P* = 0.005                                                                         *P* = 0.05                                                                                               

  5+                                                    262                                              108.3                                              0 (ref)                                                                             0 (ref)                                                                                                  

  2--4                                                  668                                              111.0                                              2.66 \[−1.80, 7.13\]                                                                3.94 \[0.60, 7.27\]                                                                                      

  0--1                                                  113                                              103.0                                              −5.27 \[−10.73, 0.20\]                                                              0.28 \[−4.48, 5.04\]                                                                                     

  Behavioural                                                                                                                                                                                                                                                                                                                                            Adjusted regression coefficient (95% CI)[b](#tmi12651-note-0017){ref-type="fn"},[c](#tmi12651-note-0018){ref-type="fn"}

  Smoking                                                                                                                                                   *P* \< 0.001                                                                        *P* = 0.41                                                                                               *P* = 0.43

  Never smoked                                          856                                              110.8                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  Ex--smoker                                            79                                               101.1                                              −9.70 \[−15.43, −3.97\]                                                             −1.20 \[−5.51, 3.12\]                                                                                    −1.16 \[−5.48, 3.16\]

  Current smoker                                        108                                              105.1                                              −5.69 \[−11.07, −0.32\]                                                             3.35 \[−1.66, 8.36\]                                                                                     3.16 \[−1.80, 8.11\]

  Alcohol consumption                                                                                                                                       *P* = 0.004                                                                         *P* = 0.91                                                                                               *P* = 0.82

  Never drinks                                          669                                              111.4                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  None in past 12 months                                237                                              106.0                                              −5.40 \[−9.41, −1.39\]                                                              0.16 \[−3.66, 3.98\]                                                                                     0.20 \[−3.61, 4.02\]

  Drinking in past 12 months                            137                                              105.6                                              −5.88 \[−10.55, −1.20\]                                                             0.83 \[−3.08, 4.74\]                                                                                     1.20 \[−2.67, 5.07\]

  Eats fruit/veg less than 5 days/week                                                                                                                      *P* = 0.08                                                                          *P* = 0.98                                                                                               *P* = 0.72

  No                                                    771                                              108.7                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  Yes                                                   272                                              111.6                                              2.88 \[−0.37, 6.13\]                                                                0.03 \[−2.80, 2.85\]                                                                                     −0.49 \[−3.29, 2.30\]

  Days of vigorous physical activity/week                                                                                                                   *P* = 0.37                                                                          *P* = 0.07                                                                                               *P* = 0.09

  5+                                                    500                                              109.6                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  1--4                                                  135                                              112.3                                              2.66 \[−2.29, 7.62\]                                                                −1.82 \[−6.34, 2.70\]                                                                                    −1.59 \[−6.05, 2.88\]

  None                                                  407                                              108.3                                              −1.33 \[−4.81, 2.15\]                                                               −3.63 \[−6.70, −0.55\]                                                                                   −3.42 \[−6.53, −0.31\]

  Clinical                                                                                                                                                                                                                                                                                                                                               Adjusted regression coefficient (95% CI)[b](#tmi12651-note-0017){ref-type="fn"},[d](#tmi12651-note-0019){ref-type="fn"}

  Body Mass Index (BMI) category (kg/m^2^)                                                                                                                  *P* \< 0.001                                                                        *P* = 0.08                                                                                               *P* = 0.12

  Underweight (\<18.5)                                  109                                              108.0                                              −3.80 \[−10.67, 3.06\]                                                              0.78 \[−4.82, 6.38\]                                                                                     0.89 \[−4.67, 6.46\]

  Normal (18.5--\<25)                                   737                                              111.8                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  Overweight (25--\<30)                                 123                                              102.8                                              −8.94 \[−13.98, −3.90\]                                                             −3.75 \[−8.69, 1.19\]                                                                                    −3.67 \[−8.68, 1.34\]

  Obese (≥30)                                           69                                               98.8                                               −13.00 \[−17.34, −8.66\]                                                            −4.69 \[−8.70, −0.69\]                                                                                   −4.32 \[−8.34, −0.29\]

  Central Obesity                                                                                                                                           *P* = 0.02                                                                          *P* = 0.27                                                                                               *P* = 0.34

  No                                                    784                                              111.4                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  Yes                                                   259                                              103.7                                              −7.70 \[−11.77, −3.63\]                                                             −2.30 \[−6.46, 1.87\]                                                                                    −1.97 \[−6.07, 2.13\]

  Hypertension                                                                                                                                              *P* \< 0.001                                                                        *P* = 0.03                                                                                               *P* = 0.05

  No                                                    863                                              112.2                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  Yes                                                   180                                              96.2                                               −16.00 \[−20.52, −11.49\]                                                           −5.45 \[−10.44, −0.46\]                                                                                  −4.85 \[−9.62, −0.09\]

  Systolic blood pressure                                                                                                                                                                                                                                                                                                                                

  \<120 mmHg                                            448                                              114.4                                              *P* \< 0.001\                                                                       *P* = 0.006\                                                                                             *P* = 0.007\
                                                                                                                                                            −3.72 \[−4.68, −2.76\][g](#tmi12651-note-0022){ref-type="fn"}                       −1.52 \[--2.58, −0.46\][g](#tmi12651-note-0022){ref-type="fn"}                                           −1.48 \[−2.52, −0.43\][g](#tmi12651-note-0022){ref-type="fn"}

  120--140 mmHg                                         445                                              109.2                                                                                                                                                                                                                                           

  \>140 mmHg                                            150                                              95.4                                                                                                                                                                                                                                            

  Diastolic blood pressure                                                                                                                                                                                                                                                                                                                               

  \<80 mmHg                                             748                                              112.7                                              *P* \< 0.001\                                                                       *P* = 0.03\                                                                                              *P* = 0.04\
                                                                                                                                                            −5.71 \[−7.42, −4.01\][g](#tmi12651-note-0022){ref-type="fn"}                       −1.93 \[−3.68, −0.17\][g](#tmi12651-note-0022){ref-type="fn"}                                            −1.87 \[--3.62, −0.11\][g](#tmi12651-note-0022){ref-type="fn"}

  80--90 mmHg                                           210                                              102.7                                                                                                                                                                                                                                           

  \>90 mmHg                                             85                                               97.8                                                                                                                                                                                                                                            

  Diabetes[e](#tmi12651-note-0020){ref-type="fn"}                                                                                                           *P* = 0.49                                                                          *P* = 0.41                                                                                               *P* = 0.32

  No                                                    1031                                             109.6                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  Yes                                                   9                                                102.9                                              −6.66 \[−26.03, 12.71\]                                                             6.65 \[−9.33, 22.62\]                                                                                    7.68 \[−7.75, 23.10\]

  HIV positive[f](#tmi12651-note-0021){ref-type="fn"}                                                                                                       *P* = 0.30                                                                          *P* = 0.40                                                                                               *P* = 0.31

  No                                                    947                                              109.6                                              0 (ref)                                                                             0 (ref)                                                                                                  0 (ref)

  Yes                                                   87                                               106.8                                              −2.73 \[−8.03, 2.57\]                                                               1.78 \[−2.41, 5.96\]                                                                                     2.09 \[−2.00, 6.17\]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Actual number of respondents and means, without sampling weights applied.

Standard errors adjusted for clustering in survey design.

Behavioural factors adjusted for age, sex, location and all independent sociodemographic predictors of GFR: number of items owned.

Clinical factors adjusted for age, sex, location, number of items owned and independent behavioural predictors of GFR: days of vigorous physical activity/week.

Missing for three participants.

HIV diagnosis missing for nine participants.

Regression coefficient for 10 unit mmHg increase in blood pressure modelled as a linear association with continuous covariate.

John Wiley & Sons, Ltd

After adjusting for sociodemographic factors, there was evidence of a decrease in mean eGFR among those with no daily vigorous activity (−3.4 \[−6.5, −0.3\]) compared with those with who engaged in vigorous activity ≥5 days a week. There was no evidence of an association with other behavioural factors. We also observed a decrease in mean eGFR associated with increasing blood pressure (adjusted regression coefficients for each 10 mmHg increase in systolic or diastolic blood pressure: −1.5 \[−2.5, −0.4\] and −1.9 \[−3.6, −0.1\], respectively). There was also weak evidence of an association with BMI, with mean eGFR being lowest among obese participants (adjusted regression coefficient −4.3 \[−8.3, −0.3\]).

Association of decreased renal function with other chronic diseases {#tmi12651-sec-0019}
-------------------------------------------------------------------

The adjusted population attributable fraction (PAF) of decreased renal function due to HIV, hypertension and diabetes was 6%, 15% and \<0.5%, respectively. The adjusted joint PAF of decreased renal function for all three risk factors was 21%. Supplementary Table [1](#tmi12651-tbl-0001){ref-type="table-wrap"} displays the association between decreased renal function and three major chronic diseases (hypertension, diabetes mellitus and HIV) in Mwanza city, district towns and rural areas. Of note, in district towns, only 7 of 23 adults with decreased renal function had any of these three chronic diseases.

Discussion {#tmi12651-sec-0020}
==========

Decreased renal function (eGFR\<60 ml/min/1.73 m^2^) is common in north‐western Tanzania, particularly after taking into account the younger age this population. In our study, the age‐standardised prevalence of decreased renal function was higher in rural areas and district towns than the prevalence of decreased renal function reported from high‐income countries. Prevalences ranged from 9% in rural areas to 11% in district towns compared with 6% in the most recent national survey in the United States [15](#tmi12651-bib-0015){ref-type="ref"}. To the best of our knowledge, this is the first population survey to describe and compare eGFR in adults in urban, semi‐urban and rural areas in SSA. Our results confirm and extend the results of previous study. In one recently published community survey of mainly urban adults in East Africa, the prevalence of kidney disease was 7% [16](#tmi12651-bib-0016){ref-type="ref"}. Two population surveys of urban areas of Central and Southern Africa found a prevalence of eGFR\<60 ml/min/1.73 m^2^ of 7--8% [17](#tmi12651-bib-0017){ref-type="ref"}, [18](#tmi12651-bib-0018){ref-type="ref"}, while in rural West Africa, the prevalence was 5% [10](#tmi12651-bib-0010){ref-type="ref"}. These results are important because an eGFR of 30--60 ml/min/1.73 m^2^ has been associated with a 20--50% increased risk of all‐cause mortality and a 50--110% increased risk of cardiovascular mortality [19](#tmi12651-bib-0019){ref-type="ref"}. The health risks related to decreased renal function may be even higher in African populations due to limited resources for the diagnosis and treatment of kidney disease [20](#tmi12651-bib-0020){ref-type="ref"}, [21](#tmi12651-bib-0021){ref-type="ref"}.

We described the factors associated with decreased renal function both as a binary and as a continuous variable. Findings in the two models supported one another. As expected, the factor most strongly associated with low eGFR was older age. Strikingly, though, decreased renal function was also common in younger age groups in our study. Among study subjects, 20‐ to 39‐year‐old dwelling in rural areas and district towns, 6--8% had eGFR \< 60 ml/min/1.73 m^2^ compared to 0.7% in the US population [22](#tmi12651-bib-0022){ref-type="ref"}.

Other factors significantly associated with lower eGFR included greater relative wealth (as determined by number of items owned) and high blood pressure. High blood pressure has consistently been shown to be been associated with decreased eGFR in prior studies from SSA [16](#tmi12651-bib-0016){ref-type="ref"}, [17](#tmi12651-bib-0017){ref-type="ref"}, [18](#tmi12651-bib-0018){ref-type="ref"}. Due to the lower prevalence of diabetes mellitus and obesity (compared to developed countries), hypertension is relatively more important than these other factors as a risk factor for kidney disease in our region [5](#tmi12651-bib-0005){ref-type="ref"}. Of note, diabetes mellitus was not associated with decreased renal function but this may have been due to both the low prevalence of diabetes mellitus and the fact that, in this community survey, we may have identified study subjects who had not had diabetes long enough to develop nephropathy. Decreased renal function was also associated with great wealth, as demonstrated in another study from East Africa [16](#tmi12651-bib-0016){ref-type="ref"}, but not with higher income.

In our study, only 21% of the decreased renal function observed was attributable to the combination of hypertension (15%), HIV (6%) and/or diabetes mellitus (\<0.5%). In contrast, a recent study reported that, worldwide, nearly 60% of kidney disease is jointly attributable to hypertension (\~45%), diabetes mellitus (\~25%) and/or high BMI (\~25%) [23](#tmi12651-bib-0023){ref-type="ref"}. Given that nearly 80% of decreased renal function observed in our study was unexplained by other chronic diseases, we are planning further studies to investigate the etiologies of kidney disease in our population. Schistosomiasis could be an important cause of kidney disease in our region [24](#tmi12651-bib-0024){ref-type="ref"}, and we have already demonstrated a strong association between kidney disease and schistosomiasis in Tanzanian children [25](#tmi12651-bib-0025){ref-type="ref"}. Post‐infectious glomerulonephritis is also thought to be one of the leading causes of kidney disease among adults in SSA [5](#tmi12651-bib-0005){ref-type="ref"}, although data are lacking. Traditional herbal medicine use is also common in SSA, and some traditional herbs are nephrotoxic [26](#tmi12651-bib-0026){ref-type="ref"}. Genetic factors such as apolipoprotein L1 (APOL1) variants may also contribute [27](#tmi12651-bib-0027){ref-type="ref"}. These infectious, post‐infectious and genetic factors could also explain the comparatively high prevalence of decreased renal function that we observed in young adults. Further studies are needed to determine the relative contribution of these factors to renal disease in our region as well as other regions of SSA.

District towns had the highest prevalence of decreased renal function, although the explanation remains uncertain. Of note, mining is the major industry in the two district towns included in our study (Kahama and Geita). Small scale, artisanal gold miners in Tanzania use mercury, which easily enters into the soil and water supply [28](#tmi12651-bib-0028){ref-type="ref"} and can cause decreased renal function [29](#tmi12651-bib-0029){ref-type="ref"}. Differences in incidence of glomerulonephritis or infections such as malaria could also be contributing. Kidney disease of unknown cause has also been observed in other poor, rural and agrarian regions around the globe and has been variously attributed to pesticide exposure, diet and hard manual labour [30](#tmi12651-bib-0030){ref-type="ref"}. Differences in eGFR between district towns, cities and rural areas could also be explained by differences in muscle mass or protein intake. Further studies are needed to investigate these possible explanations.

Strengths of our study are its large size and its design as a population‐based representative household survey. Another strength is the use of the WHO STEPS questionnaire that allows comparison to other studies [8](#tmi12651-bib-0008){ref-type="ref"}. In addition, our study was conducted in close collaboration with representatives of the Tanzanian Ministry of Health. Our results are helping to guide the Nephrology Society of Tanzania (NESOT), a partner of the Ministry of Health that was established in 2012, in their efforts to expand screening and treatment services for kidney disease in Tanzania. The NESOT community screening programme, which began in urban areas on World Kidney Day 2013, is now moving towards district towns and rural areas.

Our study also has limitations. First, because urine was not collected as part of our community survey, we could not measure either albuminuria or haematuria. As the number of participants with low eGFR was relatively small, particularly in urban areas, the resulting imprecision and wide confidence intervals of our estimates for urban areas may partly explain the low prevalence of decreased renal function that we observed. Furthermore, because there were few outcomes, our estimated ORs and 95% CIs for some risk factors may be biased. Lastly, the 72% response rate observed in our study might have led to non‐response bias, although 90% of households randomly selected for this study and 80% of individuals in those households did consent to participate. Survivor bias might also be present and could explain the low prevalence of advanced renal disease, as adults with advanced renal disease usually do not survive long in Tanzania.

In conclusion, our community‐based study of a random sample of urban and rural Tanzanian adults demonstrated a high prevalence of eGFR \< 60 ml/min/1.73 m^2^ in district towns and rural areas. Low eGFR was more common in our population than in the US population, particularly in younger age groups. Only 20% of decreased renal function could be explained by hypertension, HIV or diabetes mellitus. Therefore, further research is needed to identify additional risk factors for kidney disease in SSA. Importantly, as in Tanzania, kidney disease seems to be even more common than many other chronic diseases (such as diabetes mellitus), health services for kidney disease require urgent attention. The best strategy for whom to screen is yet to be determined, but these data provide a starting point for planning clinical trials and health service improvements.

Supporting information
======================

###### 

**Table S1.** Overlap between decreased renal function and three major risk factors (hypertension, diabetes mellitus and HIV) stratified by location among adults in a population survey in northwestern Tanzania, 2012--2013.

###### 

Click here for additional data file.
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